Response to: 'Standard dose of ustekinumab for childhood-onset deficiency of interleukin-36 receptor antagonist' by Cherqaoui et al

Bonekamp, Nadia E; Caorsi, Roberta; Frenkel, Joost; Gattorno, Marco

doi:https://doi.org/10.1136/annrheumdis-2017-212832

Response to: 'Standard dose of ustekinumab for childhood-onset deficiency of interleukin-36 receptor antagonist' by Cherqaoui et al

DSpace/Manakin Repository

Response to: 'Standard dose of ustekinumab for childhood-onset deficiency of interleukin-36 receptor antagonist' by Cherqaoui et al

Bonekamp, Nadia E; Caorsi, Roberta; Frenkel, Joost; Gattorno, Marco

(2018) Annals of the Rheumatic Diseases, volume 77, issue 12

(Comment)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: fever syndromes, inflammation, treatment, Immunology and Allergy, Rheumatology, Immunology, General Biochemistry,Genetics and Molecular Biology

DOI: https://doi.org/10.1136/annrheumdis-2017-212832

ISSN: 0003-4967

Publisher: BMJ Publishing Group

(Peer reviewed)